Inventor
VAN GAALEN MARCEL
DE11 patents
⚠️ This page may combine multiple inventors who share the name “VAN GAALEN MARCEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE DEUTSCHLAND
9 patentsUS9527856B2Dec 27, 2016
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND4 citations70
US9540370B2Jan 10, 2017
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
ABBVIE DEUTSCHLAND0 citations51
US10100048B2Oct 16, 2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
ABBVIE DEUTSCHLAND0 citations49
US9688678B2Jun 27, 2017
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND0 citations41
US9862704B2Jan 9, 2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
ABBVIE DEUTSCHLAND0 citations40
US9840495B2Dec 12, 2017
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
ABBVIE DEUTSCHLAND0 citations40
US9617226B2Apr 11, 2017
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND0 citations40
US9657002B2May 23, 2017
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases
ABBVIE DEUTSCHLAND0 citations38
US9273036B2Mar 1, 2016
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
ABBVIE DEUTSCHLAND0 citations38